BA
ALXA

BlackRock Advisors’s Alexza Pharmaceuticals Inc ALXA Stock Holding History

BlackRock Advisors’s Portfolio ALXA Stock Details ALXA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-7,669
Closed -$35K – 3762
2014
Q2 		$35K Hold
7,669
– – ﹤0.01% 3324
2014
Q1 		$34K Buy
7,669
+3,158
+70% +$16.2K ﹤0.01% 3318
2013
Q4 		$21K Buy
4,511
+732
+19% +$3.59K ﹤0.01% 3387
2013
Q3 		$19K Hold
3,779
– – ﹤0.01% 3330
2013
Q2 		$16K Buy
+3,779
New +$17.1K ﹤0.01% 3319

Other funds holding ALXA

LPA
Lansdowne Partners Austria Vienna, Austria $29M AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
CLOS
Compagnie Lombard Odier SCmA 1204 Geneva, Switzerland $9.25B AUM 27.04% 1-Year Est. Return
FAM
Fortaleza Asset Management Chicago, Illinois $12.3M AUM 48.33% 1-Year Est. Return
HHMI
Howard Hughes Medical Institute Chevy Chase, Maryland $445M AUM 42.75% 1-Year Est. Return

BlackRock Advisors's ALXA Position: Q3 2014 in Review

BlackRock Advisors sold out of Alexza Pharmaceuticals Inc (ALXA) in Q3 2014, closing a stake of 7,669 shares — an estimated $35K sold.

BlackRock Advisors first reported a position in ALXA in Q2 2013 and held it in 5 quarters. The position peaked at $35K in Q2 2014. 38 funds tracked by Wall St. Rank hold ALXA as of Q3 2014.

  • BlackRock Advisors reported no remaining Alexza Pharmaceuticals Inc position as of Q3 2014 after selling out during the quarter.
  • BlackRock Advisors sold 7,669 Alexza Pharmaceuticals Inc shares in Q3 2014, an estimated $35K.
  • BlackRock Advisors first reported a position in Alexza Pharmaceuticals Inc in Q2 2013 and held it in 5 quarters.
  • BlackRock Advisors's Alexza Pharmaceuticals Inc position peaked at $35K in Q2 2014.
  • 38 funds tracked by Wall St. Rank held Alexza Pharmaceuticals Inc as of Q3 2014.

Based on BlackRock Advisors's 13F filing for Q3 2014, filed 29 Oct 2014.